EOLS - Evolus Inc. (EOLS) Q4 2023 Earnings Call Transcript
2024-03-07 22:40:28 ET
Evolus, Inc. (EOLS)
Q4 2023 Earnings Conference Call
March 07, 2024, 04:30 PM ET
Company Participants
Nareg Sagherian - VP and Head of Global Investor Relations and Corporate Communications
David Moatazedi - President and CEO
Rui Avelar - CMO and Head, Research & Development
Sandra Beaver - CFO
Conference Call Participants
Annabel Samimy - Stifel
Louise Chen - Cantor Fitzgerald
Navann Ty - BNP Paribas
Serge Belanger - Needham & Company
Uy Ear - Mizuho Securities
Douglas Tsao - H.C. Wainwright
Presentation
Operator
Good afternoon, everyone, and thank you for standing by. Welcome to Evolus' Fourth Quarter and Full Year 2023 Earnings Conference Call. As a reminder, today's conference is being recorded and webcast live. [Operator Instructions]
I would now like to turn the conference over to Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead.
Nareg Sagherian
Thank you, operator, and welcome to everyone joining us on today's call to review Evolus' fourth quarter and full year 2023 financial results. Our fourth quarter and full year 2023 press release is now on our website at evolus.com.
With me today are David Moatazedi, President and Chief Executive Officer; Rui Avelar, Chief Medical Officer and Head of R&D; and Sandra Beaver, Chief Financial Officer.
Before we begin our discussion, I'd like to note that during our call, our prepared remarks will include forward-looking statements within the meaning of United States securities laws and management's additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's strategy, operations or financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this call, and the company undertakes no obligation to update or review any estimate, projection or forward-looking statements, except as required by law....
Evolus, Inc. (EOLS) Q4 2023 Earnings Call Transcript